In partnership with Clinical Care Options, GRACE Founder and President H. Jack West, MD provides this informational video regarding immunotherapy for...
3rd Line and beyond
3rd Line and beyond
If you have been NEWLY DIAGNOSED START HERE
Video Library
Cancer Journey:
Cancer Type:
Disease Learning:
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal approach for a fit patient with advanced squamous NSCLC and low tumor PD-L1 expression.
Cancer Journey:
Cancer Type:
Dr. Karen Reckamp, MD, MS, City of Hope Comprehensive Cancer Center in Duarte, California joined GRACE to discuss the role of immunotherapy for previously treated patients with non-small cell lung cancer.
Cancer Journey:
Cancer Type:
Disease Learning:
, ,
Download the speaker presentations and handouts from the Targeted Therapies Patient Forum in Cleveland at the Taussig Cancer Center on September 16, 2017.
Cancer Journey:
Cancer Type:
Transcript I think there are several goals when treating a patient with advanced non-small cell lung cancer. For one I think we want to extend life,...
Cancer Journey:
Cancer Type:
- 1 of 2
- View More
Articles
From the Grace Archives | Originally P ublished December 6, 2006 | By Dr West | 25 Comments Bronchioloalveolar carcinoma, or BAC , is a subtype of...
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. West moderates a question & answer session with Drs. Karen Reckamp and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for patients with advanced NSCLC that harbors a driver mutation.
Cancer Journey:
Cancer Type:
Disease Learning:
Every few months I see a patient who reminds me of the fallability of mutation testing. One of the brightest rays of hope in the management of lung...
Cancer Journey:
Cancer Type:
Disease Learning:
Almost exactly a year ago, I reported that the large MARQUEE trial of EGFR inhibitor Tarceva (erlotinib) plus either the MET inhibitor tivantinib (...
Cancer Journey:
Cancer Type:
Disease Learning:
With the recent approval of afatinib, now becoming commercially available as Gilotrif, there is the potential new strategy for patients with an EGFR...
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 17
- View More
Community Forum
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for...
Cancer Journey:
Cancer Type:
Has anyone any information on obtaining and using Vaxira, the Cuban drug, for stage 4 advanced NSCLC? Not sure if US citizens can still travel to...
Cancer Journey:
Cancer Type:
Disease Learning: